Proven across a broad range of complex cases, the versatility of the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface* enables you to deliver high patency and durable outcomes to minimize interventions for your patients.
Data on file 2017; W. L. Gore & Associates, Inc; Flagstaff, AZ.
Performance evolution through collaboration
The GORE® VIABAHN® Endoprosthesis is the leader among stent grafts.** Decades of partnership with clinicians around the globe has resulted in unparalleled performance across multiple indications. The GORE® VIABAHN® Endoprosthesis features:
- Lengths up to 25 cm
- Low profile design
- Multiple FDA approved indications for use
- Radiopaque markers
- Proven CBAS Heparin Surface* technology†
** Based on Millennium Research Group, Inc. data, reflecting unit and revenue share, June 2018.
† CBAS Heparin Suface. W. L. Gore & Associates Web site. https://www.goremedical.com/cbas/references. Accessed July 30, 2018.